Analysis

Features

From Nobel to next-gen: Sweden’s quiet life sciences ascent

Sweden’s place on the frontier of science has a long history, with the capital Stockholm coming to a standstill every…

Features

New US biotech hubs showing potential amid onshoring request

Features

Pharma R&D set to endure despite rising MFN costs

Features

NewCo licensing models are tipping deals in favour of China’s biotechs

Comment

The dangerous second life of medical waste

Features

The Baltics: a region punching above its weight on the global life sciences stage

Features

Magazine: China’s CGT edge

Features

What does the EU Data Act mean for businesses?

Features

Features

As US funding falters, mRNA cancer vaccine pioneers face new hurdles

Features

Podcast: key trials and trends from ESC Congress 2025

Features

Cell and gene therapies on correction course but not sinking

Comment

Comment

The curtain closes on a successful World Investment Conference in New Delhi

Comment

Cloud in pharma: Q&A with GlobalData thematic analyst

Comment

AI in pharma: Q&A with GlobalData thematic analyst

Data Insights

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Data Insights

Coronavirus Disease 2019 (COVID-19) vaccine by China National Biotec Group for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval

Data Insights

Fosigotifator by Calico Life Sciences for Unspecified Central Nervous System Disorders: Likelihood of Approval

Projects

Projects

Evergreen Theragnostics Radiopharmaceutical Manufacturing Facility, New Jersey, US

Projects

Eli Lilly Biologic Active Ingredients Manufacturing Facility Expansion, Limerick, Ireland

Projects

Almac Group North American Headquarters Expansion, Pennsylvania, USA

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Pharmaceutical Technology Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close